Np mrd loader

Record Information
Version1.0
Created at2020-12-09 02:10:48 UTC
Updated at2021-07-15 16:50:05 UTC
NP-MRD IDNP0004758
Secondary Accession NumbersNone
Natural Product Identification
Common NameWS 009 B
Provided ByNPAtlasNPAtlas Logo
Description3-[(4A,6,8,12a,12b-pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid belongs to the class of organic compounds known as hydroxyanthraquinones. Hydroxyanthraquinones are compounds containing a hydroxyanthraquinone moiety, which consists of an anthracene bearing a quinone, and hydroxyl group. WS 009 B is found in Streptomyces sp. It was first documented in 1992 (PMID: 1325433). Based on a literature review very few articles have been published on 3-[(4a,6,8,12a,12b-pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid (PMID: 26389497) (PMID: 26389486) (PMID: 26389480) (PMID: 26389479).
Structure
Data?1624574199
Synonyms
ValueSource
3-[(4a,6,8,12a,12b-Pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoateGenerator
3-[(4a,6,8,12a,12b-Pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl)sulphanyl]-2-[(1-hydroxyethylidene)amino]propanoateGenerator
3-[(4a,6,8,12a,12b-Pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl)sulphanyl]-2-[(1-hydroxyethylidene)amino]propanoic acidGenerator
WS 009bMeSH
Chemical FormulaC24H25NO11S
Average Mass535.5200 Da
Monoisotopic Mass535.11483 Da
IUPAC Name(2S)-3-{[(4aS,6R,6aS,12aS,12bS)-4a,6,8,12a,12b-pentahydroxy-3-methyl-1,7,12-trioxo-1,4,4a,5,6,6a,7,12,12a,12b-decahydrotetraphen-6a-yl]sulfanyl}-2-acetamidopropanoic acid
Traditional Name(2S)-3-{[(4aS,6R,6aS,12aS,12bS)-4a,6,8,12a,12b-pentahydroxy-3-methyl-1,7,12-trioxo-5,6-dihydro-4H-tetraphen-6a-yl]sulfanyl}-2-acetamidopropanoic acid
CAS Registry NumberNot Available
SMILES
CC(=O)NC(CSC12C(O)CC3(O)CC(C)=CC(=O)C3(O)C1(O)C(=O)C1=C(C(O)=CC=C1)C2=O)C(O)=O
InChI Identifier
InChI=1S/C24H25NO11S/c1-10-6-15(28)23(35)21(34,7-10)8-16(29)22(37-9-13(20(32)33)25-11(2)26)19(31)17-12(4-3-5-14(17)27)18(30)24(22,23)36/h3-6,13,16,27,29,34-36H,7-9H2,1-2H3,(H,25,26)(H,32,33)
InChI KeyJTSMUTXXQIUBJR-UHFFFAOYSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Streptomyces sp.NPAtlas
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hydroxyanthraquinones. Hydroxyanthraquinones are compounds containing a hydroxyanthraquinone moiety, which consists of an anthracene bearing a quinone, and hydroxyl group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassAnthracenes
Sub ClassAnthraquinones
Direct ParentHydroxyanthraquinones
Alternative Parents
Substituents
  • Hydroxyanthraquinone
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • Cysteine or derivatives
  • Alpha-amino acid or derivatives
  • Tetralin
  • Naphthalene
  • Aryl alkyl ketone
  • Aryl ketone
  • Quinone
  • Cyclohexenone
  • 1-hydroxy-2-unsubstituted benzenoid
  • 1-hydroxy-4-unsubstituted benzenoid
  • Cyclic alcohol
  • Tertiary alcohol
  • Acetamide
  • Vinylogous acid
  • Carboxamide group
  • Ketone
  • Secondary alcohol
  • Secondary carboxylic acid amide
  • Polyol
  • Thioether
  • Sulfenyl compound
  • Carboxylic acid derivative
  • Dialkylthioether
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organosulfur compound
  • Organic oxide
  • Organic nitrogen compound
  • Organopnictogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Alcohol
  • Organooxygen compound
  • Carbonyl group
  • Aromatic homopolycyclic compound
Molecular FrameworkAromatic homopolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0.02ALOGPS
logP-1ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)3.09ChemAxon
pKa (Strongest Basic)-3.2ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count11ChemAxon
Hydrogen Donor Count7ChemAxon
Polar Surface Area218.76 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity127.13 m³·mol⁻¹ChemAxon
Polarizability50.51 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
NPAtlas IDNPA016773
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9931638
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11756937
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Miyata S, Ohhata N, Murai H, Masui Y, Ezaki M, Takase S, Nishikawa M, Kiyoto S, Okuhara M, Kohsaka M: WS009 A and B, new endothelin receptor antagonists isolated from Streptomyces sp. no. 89009. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo). 1992 Jul;45(7):1029-40. doi: 10.7164/antibiotics.45.1029. [PubMed:1325433 ]
  2. Authors unspecified: Lung Cancer Prevention (PDQ(R)): Patient Version. 2002. [PubMed:26389497 ]
  3. Authors unspecified: Endometrial Cancer Screening (PDQ(R)): Patient Version. 2002. [PubMed:26389486 ]
  4. Authors unspecified: Ewing Sarcoma and Undifferentiated Small Round Cell Sarcomas of Bone and Soft Tissue Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389480 ]
  5. Authors unspecified: Bladder Cancer Treatment (PDQ(R)): Patient Version. 2002. [PubMed:26389479 ]